A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/33879804/ below:

Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy)

. 2021 Apr 20;11(1):8530. doi: 10.1038/s41598-021-87864-x. Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy)

Affiliations

Affiliations

Item in Clipboard

Subsequent attendance in a breast cancer screening program after a false-positive result in the Local Health Authority of Bologna (Italy)

Lorena Squillace et al. Sci Rep. 2021.

. 2021 Apr 20;11(1):8530. doi: 10.1038/s41598-021-87864-x. Affiliations

Item in Clipboard

Abstract

We conducted a cross-sectional study to assess the likelihood of returning for routine breast cancer screening among women who have experienced a false-positive result (FPR) and to describe the possible individual and organizational factors that could influence subsequent attendance to the screening program. Several information were collected on demographic and clinical characteristics data. Electronic data from 2014 to 2016 related to breast screening program of the Local Health Authority (LHA) of Bologna (Italy) of women between 45 and 74 years old were reviewed. A total of 4847 women experienced an FPR during mammographic screening and were recalled to subsequent round; 80.2% adhered to the screening. Mean age was 54.2 ± 8.4 years old. Women resulted to be less likely to adhere to screening if they were not-Italian (p = 0.001), if they lived in the Bologna district (p < 0.001), if they had to wait more than 5 days from II level test to end of diagnostic procedures (p = 0.001), if the diagnostic tests were performed in a hospital with the less volume of activity and higher recall rate (RR) (p < 0.001) and if they had no previous participation to screening tests (p < 0.001). Our results are consistent with previous studies, and encourages the implementation and innovation of the organizational characteristics for breast cancer screening. The success of screening programs requires an efficient indicators monitoring strategy to develop and evaluate continuous improvement processes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1

Flow-chart of women’s enrolment.

Figure 1

Flow-chart of women’s enrolment.

Figure 1

Flow-chart of women’s enrolment.

References
    1. Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac. J. Cancer Prev. 2016;17:43–46. doi: 10.7314/APJCP.2016.17.S3.43. - DOI - PubMed
    1. Nelson HD, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009;151:727–742. doi: 10.7326/0003-4819-151-10-200911170-00009. - DOI - PMC - PubMed
    1. Tabar L, et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003;361:1405–1410. doi: 10.1016/S0140-6736(03)13143-1. - DOI - PubMed
    1. Hubbard RA, et al. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann. Intern. Med. 2011;155:481–492. doi: 10.7326/0003-4819-155-8-201110180-00004. - DOI - PMC - PubMed
    1. Elmore JG, et al. Ten-year risk of false-positive screening mammograms and clinical breast examinations. N. Engl. J. Med. 1998;338:1089–1096. doi: 10.1056/NEJM199804163381601. - DOI - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3